MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...

MiNK Therapeutics Inc. INKT shares are up on Tuesday as the company has announced a strategic collaboration with C-Further to ...

Selected as a C-Further program with up to $1.1 million in non-dilutive, aggregate payments to advance IND-enabling development, with potential for meaningful double-digit downstream commercial ...

Cabin fever was the word of the year for 2020, especially for those accustomed to traveling whichever chance they got. For them and many others suddenly left without the means to go on vacation, ...

MiNK Therapeutics collaborates with C-Further to advance PRAME-targeted iNKT cell therapy for paediatric cancer: New York Thursday, March 12, 2026, 10:00 Hrs [IST] MiNK Therapeuti ...

MiNK Therapeutics Inc. INKT shares are down during Wednesday’s premarket session, possibly on profit-taking after the stock rallied roughly 30% on Tuesday. On Tuesday, the company announced a ...

Mink Ventures Corporation (TSXV:MINK) (“Mink ” or the "Company ") today announced that it has completed a single, vertical drill hole (549 meters) at its Montcalm Ni Cu Co project, Timmins Ontario ...

Denmark began the unpleasant task of exhuming millions of mink Thursday to safeguard nearby waters from contamination by poorly-dug graves of mink culled last year to prevent the spread of mutant ...

The Danish government has ordered the country’s mink farms to cull over 1 million mink due to a series of Covid-19 outbreaks among the animals. The current outbreak is believed to have started in late ...